Financhill
Buy
51

FHTX Quote, Financials, Valuation and Earnings

Last price:
$5.35
Seasonality move :
-23.21%
Day range:
$5.25 - $5.54
52-week range:
$2.94 - $6.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.46x
P/B ratio:
--
Volume:
73.4K
Avg. volume:
191K
1-year change:
7.57%
Market cap:
$305.4M
Revenue:
$22.6M
EPS (TTM):
-$1.19

Earnings Data

Next earnings date for FHTX
Mar 05
2026
Most recent earnings per share
-$0.25
Beat by $0.05
(Nov 5/2025)
Consensus Estimate
-$0.30
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

FHTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/05/2026 Q4 $9.5M -- -- -$0.27 --
11/05/2025 Q3 $6.2M $8.2M -$0.25 -$0.30 $0.05
08/05/2025 Q2 $7.1M $7.6M -$0.28 -$0.32 $0.03
05/12/2025 Q1 $5M $6M -$0.30 -$0.29 -$0.01
03/06/2025 Q4 $8.7M $2.9M -$0.35 -$0.29 -$0.07
11/04/2024 Q3 $7M $7.8M -$0.31 -$0.43 $0.12
08/08/2024 Q2 $6.7M $6.9M -$0.45 -$0.64 $0.19
05/06/2024 Q1 $7.4M $5.1M -$0.59 -$0.59 --
12/31/2023 Q4 $5.8M $5.8M -$0.57 -$0.70 $0.13
11/02/2023 Q3 -- -- -$0.34 -$0.65 $0.31
06/30/2023 Q2 -- -- -$0.70 -$0.69 -$0.01
03/31/2023 Q1 -- -- -$0.73 -$0.66 -$0.07
12/31/2022 Q4 -- -- -$0.69 -$0.54 -$0.15
09/30/2022 Q3 -- -- -$0.62 -$0.50 -$0.12
06/30/2022 Q2 -- -- -$0.66 -$0.41 -$0.25
03/31/2022 Q1 -- -- -$0.65 -$0.47 -$0.18
12/31/2021 Q4 -- -- -$0.77 -- --
09/30/2021 Q3 -- -- -$0.71 -- --
06/30/2021 Q2 -- -- -$0.63 -- --
03/31/2021 Q1 -- -- -$0.62 -- --
12/31/2020 Q4 -- -- -$0.56 -- --
09/30/2020 Q3 -- -- -$0.51 -- --
06/30/2020 Q2 -- -- -$0.71 -- --
03/31/2020 Q1 -- -- -$0.63 -- --
12/31/2019 Q4 -- -- -$0.69 -- --
09/30/2019 Q3 -- -- -$0.59 -- --

Foghorn Therapeutics, Inc. Earnings Questions

  • How Much did Foghorn Therapeutics, Inc. Generate in Revenue Last Quarter?

    Foghorn Therapeutics, Inc. reported $8.2M worth of top line sales in its most recent quarter.

  • Did Foghorn Therapeutics, Inc. Beat Earnings Last Quarter?

    Foghorn Therapeutics, Inc. announced earnings per share of -$0.25 which represents a beat of analyst forecast a -$0.30 per share.

  • Is Foghorn Therapeutics, Inc. Profitable?

    Foghorn Therapeutics, Inc. reported $7.3M that represents $0.12 per share over the last quarter.

  • What is the Analyst Consensus for Foghorn Therapeutics, Inc. EPS Next Year?

    Foghorn Therapeutics, Inc.'s earnings are forecast to decrease from -$1.58 per share to -$1.48 per share next year representing a decrease of -29.93%.

  • When is Foghorn Therapeutics, Inc.'s Earnings Date?

    Foghorn Therapeutics, Inc.'s next earnings date is March 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 26

Travere Therapeutics, Inc. [TVTX] is down 0.57% over the past day.

Buy
64
ZCSH alert for Dec 26

Grayscale Zcash Trust (ZEC) [ZCSH] is down 1.33% over the past day.

Buy
66
ASTS alert for Dec 26

AST Spacemobile, Inc. [ASTS] is down 7.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock